PMC-002R

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePMC-002R

Drug Alias NamePMC-002R

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsTEK receptor tyrosine kinase antagonists

TargetsTEK receptor tyrosine kinaseVascular endothelial growth factor receptor 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharmabcine

China Registration ClassN/A

Develop Information

Active CompaniesPharmabcine

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A